Mucopolysaccharidosis type I (Hurler syndrome) and anesthesia: the impact of bone marrow transplantation, enzyme replacement therapy, and fiberoptic intubation on airway management

Summary Aim:  To assess the effect of bone marrow transplantation (BMT), enzyme replacement therapy (ERT), and a fiberoptic endotracheal intubation technique in patients with mucopolysaccharidosis type I (MPS I, Hurler syndrome). Background:  The mucopolysaccharidoses are inherited metabolic conditi...

Full description

Saved in:
Bibliographic Details
Published inPediatric anesthesia Vol. 22; no. 8; pp. 745 - 751
Main Authors Kirkpatrick, Katherine, Ellwood, James, Walker, Robert W. M.
Format Journal Article
LanguageEnglish
Published Oxford, UK Blackwell Publishing Ltd 01.08.2012
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Summary Aim:  To assess the effect of bone marrow transplantation (BMT), enzyme replacement therapy (ERT), and a fiberoptic endotracheal intubation technique in patients with mucopolysaccharidosis type I (MPS I, Hurler syndrome). Background:  The mucopolysaccharidoses are inherited metabolic conditions with a well‐documented association with difficult airway management. We present the largest series to date of patients with Hurler syndrome (MPS I) and look at the impact of new treatments, such as BMT and ERT, on anesthesia and airway management. Methods/Materials:  We carried out a retrospective chart review of patients with MPSI undergoing anesthesia over 9 years at the Royal Manchester Children’s Hospital. Data were collected on incidence of difficult and failed intubation and airway difficulties under anesthesia. Results:  There were 39 patients identified, of which 20 had the attenuated form of MPS I and received ERT, 18 were treated by BMT and one patient received neither treatment. These patients had a total of 114 general anesthetics for 141 procedures. The incidence of airway complications overall is lower than previously reported at 31%. Patients with the attenuated form of the disease on ERT still have a high incidence of airway problems at 57% and a failed intubation rate of 3%. BMT patients on the other hand have a much lower incidence of airway complications at 14%, and there were no failed intubations in this group. Conclusions:  Managing the MPS1 patient continues to be a challenge but with treatment and newer forms of airway management it is improving.
AbstractList Aim:  To assess the effect of bone marrow transplantation (BMT), enzyme replacement therapy (ERT), and a fiberoptic endotracheal intubation technique in patients with mucopolysaccharidosis type I (MPS I, Hurler syndrome). Background:  The mucopolysaccharidoses are inherited metabolic conditions with a well‐documented association with difficult airway management. We present the largest series to date of patients with Hurler syndrome (MPS I) and look at the impact of new treatments, such as BMT and ERT, on anesthesia and airway management. Methods/Materials:  We carried out a retrospective chart review of patients with MPSI undergoing anesthesia over 9 years at the Royal Manchester Children’s Hospital. Data were collected on incidence of difficult and failed intubation and airway difficulties under anesthesia. Results:  There were 39 patients identified, of which 20 had the attenuated form of MPS I and received ERT, 18 were treated by BMT and one patient received neither treatment. These patients had a total of 114 general anesthetics for 141 procedures. The incidence of airway complications overall is lower than previously reported at 31%. Patients with the attenuated form of the disease on ERT still have a high incidence of airway problems at 57% and a failed intubation rate of 3%. BMT patients on the other hand have a much lower incidence of airway complications at 14%, and there were no failed intubations in this group. Conclusions:  Managing the MPS1 patient continues to be a challenge but with treatment and newer forms of airway management it is improving.
Summary Aim: To assess the effect of bone marrow transplantation (BMT), enzyme replacement therapy (ERT), and a fiberoptic endotracheal intubation technique in patients with mucopolysaccharidosis type I (MPS I, Hurler syndrome). Background: The mucopolysaccharidoses are inherited metabolic conditions with a well-documented association with difficult airway management. We present the largest series to date of patients with Hurler syndrome (MPS I) and look at the impact of new treatments, such as BMT and ERT, on anesthesia and airway management. Methods/Materials: We carried out a retrospective chart review of patients with MPSI undergoing anesthesia over 9 years at the Royal Manchester Children's Hospital. Data were collected on incidence of difficult and failed intubation and airway difficulties under anesthesia. Results: There were 39 patients identified, of which 20 had the attenuated form of MPS I and received ERT, 18 were treated by BMT and one patient received neither treatment. These patients had a total of 114 general anesthetics for 141 procedures. The incidence of airway complications overall is lower than previously reported at 31%. Patients with the attenuated form of the disease on ERT still have a high incidence of airway problems at 57% and a failed intubation rate of 3%. BMT patients on the other hand have a much lower incidence of airway complications at 14%, and there were no failed intubations in this group. Conclusions: Managing the MPS1 patient continues to be a challenge but with treatment and newer forms of airway management it is improving. [PUBLICATION ABSTRACT]
To assess the effect of bone marrow transplantation (BMT), enzyme replacement therapy (ERT), and a fiberoptic endotracheal intubation technique in patients with mucopolysaccharidosis type I (MPS I, Hurler syndrome).AIMTo assess the effect of bone marrow transplantation (BMT), enzyme replacement therapy (ERT), and a fiberoptic endotracheal intubation technique in patients with mucopolysaccharidosis type I (MPS I, Hurler syndrome).The mucopolysaccharidoses are inherited metabolic conditions with a well-documented association with difficult airway management. We present the largest series to date of patients with Hurler syndrome (MPS I) and look at the impact of new treatments, such as BMT and ERT, on anesthesia and airway management.BACKGROUNDThe mucopolysaccharidoses are inherited metabolic conditions with a well-documented association with difficult airway management. We present the largest series to date of patients with Hurler syndrome (MPS I) and look at the impact of new treatments, such as BMT and ERT, on anesthesia and airway management.We carried out a retrospective chart review of patients with MPSI undergoing anesthesia over 9 years at the Royal Manchester Children's Hospital. Data were collected on incidence of difficult and failed intubation and airway difficulties under anesthesia.METHODS/MATERIALSWe carried out a retrospective chart review of patients with MPSI undergoing anesthesia over 9 years at the Royal Manchester Children's Hospital. Data were collected on incidence of difficult and failed intubation and airway difficulties under anesthesia.There were 39 patients identified, of which 20 had the attenuated form of MPS I and received ERT, 18 were treated by BMT and one patient received neither treatment. These patients had a total of 114 general anesthetics for 141 procedures. The incidence of airway complications overall is lower than previously reported at 31%. Patients with the attenuated form of the disease on ERT still have a high incidence of airway problems at 57% and a failed intubation rate of 3%. BMT patients on the other hand have a much lower incidence of airway complications at 14%, and there were no failed intubations in this group.RESULTSThere were 39 patients identified, of which 20 had the attenuated form of MPS I and received ERT, 18 were treated by BMT and one patient received neither treatment. These patients had a total of 114 general anesthetics for 141 procedures. The incidence of airway complications overall is lower than previously reported at 31%. Patients with the attenuated form of the disease on ERT still have a high incidence of airway problems at 57% and a failed intubation rate of 3%. BMT patients on the other hand have a much lower incidence of airway complications at 14%, and there were no failed intubations in this group.Managing the MPS1 patient continues to be a challenge but with treatment and newer forms of airway management it is improving.CONCLUSIONSManaging the MPS1 patient continues to be a challenge but with treatment and newer forms of airway management it is improving.
To assess the effect of bone marrow transplantation (BMT), enzyme replacement therapy (ERT), and a fiberoptic endotracheal intubation technique in patients with mucopolysaccharidosis type I (MPS I, Hurler syndrome). The mucopolysaccharidoses are inherited metabolic conditions with a well-documented association with difficult airway management. We present the largest series to date of patients with Hurler syndrome (MPS I) and look at the impact of new treatments, such as BMT and ERT, on anesthesia and airway management. We carried out a retrospective chart review of patients with MPSI undergoing anesthesia over 9 years at the Royal Manchester Children's Hospital. Data were collected on incidence of difficult and failed intubation and airway difficulties under anesthesia. There were 39 patients identified, of which 20 had the attenuated form of MPS I and received ERT, 18 were treated by BMT and one patient received neither treatment. These patients had a total of 114 general anesthetics for 141 procedures. The incidence of airway complications overall is lower than previously reported at 31%. Patients with the attenuated form of the disease on ERT still have a high incidence of airway problems at 57% and a failed intubation rate of 3%. BMT patients on the other hand have a much lower incidence of airway complications at 14%, and there were no failed intubations in this group. Managing the MPS1 patient continues to be a challenge but with treatment and newer forms of airway management it is improving.
Summary Aim:  To assess the effect of bone marrow transplantation (BMT), enzyme replacement therapy (ERT), and a fiberoptic endotracheal intubation technique in patients with mucopolysaccharidosis type I (MPS I, Hurler syndrome). Background:  The mucopolysaccharidoses are inherited metabolic conditions with a well‐documented association with difficult airway management. We present the largest series to date of patients with Hurler syndrome (MPS I) and look at the impact of new treatments, such as BMT and ERT, on anesthesia and airway management. Methods/Materials:  We carried out a retrospective chart review of patients with MPSI undergoing anesthesia over 9 years at the Royal Manchester Children’s Hospital. Data were collected on incidence of difficult and failed intubation and airway difficulties under anesthesia. Results:  There were 39 patients identified, of which 20 had the attenuated form of MPS I and received ERT, 18 were treated by BMT and one patient received neither treatment. These patients had a total of 114 general anesthetics for 141 procedures. The incidence of airway complications overall is lower than previously reported at 31%. Patients with the attenuated form of the disease on ERT still have a high incidence of airway problems at 57% and a failed intubation rate of 3%. BMT patients on the other hand have a much lower incidence of airway complications at 14%, and there were no failed intubations in this group. Conclusions:  Managing the MPS1 patient continues to be a challenge but with treatment and newer forms of airway management it is improving.
Author Kirkpatrick, Katherine
Ellwood, James
Walker, Robert W. M.
Author_xml – sequence: 1
  givenname: Katherine
  surname: Kirkpatrick
  fullname: Kirkpatrick, Katherine
  organization: Royal Manchester Children's Hospital, Manchester, UK
– sequence: 2
  givenname: James
  surname: Ellwood
  fullname: Ellwood, James
  organization: Royal Manchester Children's Hospital, Manchester, UK
– sequence: 3
  givenname: Robert W. M.
  surname: Walker
  fullname: Walker, Robert W. M.
  organization: Royal Manchester Children's Hospital, Manchester, UK
BackLink https://www.ncbi.nlm.nih.gov/pubmed/22672476$$D View this record in MEDLINE/PubMed
BookMark eNqNkttu1DAQhi1URNuFV0CWuClSs9hx7CRIIFUVtIVSkMrh0nKcCfU2sYOdaBueiwfE2W170atGjnz6v9_2zOyjHessIIQpWdL4vVktaSZIUvIyXaaEpkvCijJf3jxBe_cbO3FMOU-4yPgu2g9hRQhlqUifod00FXma5WIP_fsyate7dgpK6yvlTe2CCXiYesBn-OB09C14HCZbe9fBa6xsHX8IwxUEo97i2GPT9UoP2DW4itfEnfLerfHglQ19q-ygBuPsIQb7d-oAe4iLGjqww0x71U-HG9vGVOBdPxiNjR3GaoPh2JTxazVFX6t-b7jn6Gmj2gAvbvsF-vHxw_fj0-T868nZ8dF5ojPG86TMSUGLlBZxIhoumFKUNRoEECUqLhTU0Oi6yFSRU2BEUyEKkpe8YIIVqmILdLD17b37M8ZHy84EDW18FLgxSEpSxllGWRmlrx5IV270Nt5OUsayMhUi2i7Qy1vVWHVQy96bGK1J3uUjCt5vBdq7EDw0Uptt_GI4TRtPlHMByJWc8yznPMu5AOSmAORNNCgeGNyd8Qj03RZdmxamR3Py29HFPIp8suVNGODmnlf-Woqc5Vz-ujiRl_zyEy9_fo5R-Q-zG9no
CitedBy_id crossref_primary_10_1186_s13023_015_0255_4
crossref_primary_10_1111_pan_13640
crossref_primary_10_1007_s00540_016_2180_7
crossref_primary_10_1111_pan_12370
crossref_primary_10_4103_joacp_JOACP_532_20
crossref_primary_10_1177_0310057X1604400612
crossref_primary_10_3390_reports5010010
crossref_primary_10_1302_0301_620X_99B9_BJJ_2017_0487
crossref_primary_10_1111_pan_13787
crossref_primary_10_1016_j_ymgme_2014_03_013
crossref_primary_10_1093_bjaceaccp_mku004
crossref_primary_10_1016_j_redar_2012_12_008
crossref_primary_10_3390_jcm10163518
crossref_primary_10_1093_bja_aet411
crossref_primary_10_1016_j_bbmt_2019_02_012
crossref_primary_10_1148_rg_2016150168
crossref_primary_10_1186_s13052_018_0554_1
crossref_primary_10_1517_21678707_2015_1016908
crossref_primary_10_1177_2326409815616392
crossref_primary_10_7759_cureus_10582
crossref_primary_10_3390_biom11020189
crossref_primary_10_1007_s13691_024_00702_5
crossref_primary_10_1136_bcr_2012_008148
crossref_primary_10_1111_pan_13379
crossref_primary_10_1183_09059180_00008012
crossref_primary_10_1016_j_beem_2014_08_005
crossref_primary_10_3390_jcm10153275
crossref_primary_10_1371_journal_pone_0203216
crossref_primary_10_3390_ijms21082975
crossref_primary_10_12688_f1000research_23532_1
crossref_primary_10_1213_ANE_0000000000001689
crossref_primary_10_3390_cells9081838
crossref_primary_10_1007_s00381_018_3834_6
crossref_primary_10_1007_s10545_012_9563_1
crossref_primary_10_1016_j_ncl_2013_04_007
crossref_primary_10_1097_AIA_0000000000000131
Cites_doi 10.1016/S0140-6736(81)91046-1
10.1016/j.ymgme.2006.08.007
10.1046/j.1460-9592.1997.d01-102.x
10.1038/sj.bmt.1705718
10.1097/01241398-200401000-00019
10.1016/j.amjcard.2006.02.047
10.1177/0310057X9602400408
10.1542/peds.2008-0416
10.1111/j.1365-2044.1994.tb04360.x
10.1046/j.1460-9592.2000.00425.x
10.1046/j.1460-9592.2003.00969.x
10.1016/j.jpeds.2004.01.046
10.1177/0310057X8301100303
ContentType Journal Article
Copyright 2012 Blackwell Publishing Ltd
2012 Blackwell Publishing Ltd.
Copyright 2012 Blackwell Publishing Ltd
Copyright_xml – notice: 2012 Blackwell Publishing Ltd
– notice: 2012 Blackwell Publishing Ltd.
– notice: Copyright 2012 Blackwell Publishing Ltd
DBID BSCLL
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
K9.
7X8
DOI 10.1111/j.1460-9592.2012.03897.x
DatabaseName Istex
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitleList CrossRef
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1460-9592
EndPage 751
ExternalDocumentID 2951047891
22672476
10_1111_j_1460_9592_2012_03897_x
PAN3897
ark_67375_WNG_S5SJ59VK_1
Genre article
Journal Article
GroupedDBID ---
.3N
.GA
.GJ
.Y3
05W
0R~
10A
123
1OB
1OC
29O
31~
33P
36B
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5HH
5LA
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAKAS
AANLZ
AAONW
AASGY
AAXRX
AAZKR
ABCQN
ABCUV
ABDBF
ABEML
ABJNI
ABLJU
ABOCM
ABPPZ
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFO
ACGFS
ACGOF
ACMXC
ACPOU
ACSCC
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZCM
ADZMN
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFPM
AFGKR
AFPWT
AFZJQ
AHBTC
AHEFC
AHMBA
AIACR
AIAGR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ASPBG
ATUGU
AUOVR
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BSCLL
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DC6
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EAD
EAP
EAS
EBC
EBD
EBS
EBX
EJD
EMB
EMK
EMOBN
ESX
EX3
F00
F01
F04
F5P
FEDTE
FUBAC
FZ0
G-S
G.N
GODZA
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IHE
IX1
J0M
K48
KBYEO
L7B
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
NF~
O66
O9-
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
R.K
RIWAO
RJQFR
ROL
RX1
SAMSI
SUPJJ
SV3
TEORI
TUS
UB1
V8K
V9Y
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WOW
WQJ
WRC
WUP
WVDHM
WXI
WXSBR
XG1
YFH
YUY
ZZTAW
~IA
~WT
AAHQN
AAIPD
AAMNL
AANHP
AAYCA
ACRPL
ACUHS
ACYXJ
ADNMO
AFWVQ
ALVPJ
AAYXX
AEYWJ
AGHNM
AGQPQ
AGYGG
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
K9.
7X8
ID FETCH-LOGICAL-c4357-9708182183576f563aa13fce6e0a6b56aedefcd84a871e30c1668079583638ab3
IEDL.DBID DR2
ISSN 1155-5645
1460-9592
IngestDate Thu Jul 10 22:24:50 EDT 2025
Fri Jul 25 06:45:11 EDT 2025
Wed Feb 19 02:03:00 EST 2025
Tue Jul 01 02:22:25 EDT 2025
Thu Apr 24 22:54:15 EDT 2025
Wed Jan 22 16:36:07 EST 2025
Wed Oct 30 09:49:00 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 8
Language English
License http://onlinelibrary.wiley.com/termsAndConditions#vor
2012 Blackwell Publishing Ltd.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4357-9708182183576f563aa13fce6e0a6b56aedefcd84a871e30c1668079583638ab3
Notes istex:B0A966C41876BFA3751109DD9A61379A8168591C
ark:/67375/WNG-S5SJ59VK-1
ArticleID:PAN3897
Section Editor: Brian Anderson
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
PMID 22672476
PQID 1334926658
PQPubID 1036358
PageCount 7
ParticipantIDs proquest_miscellaneous_1023534139
proquest_journals_1334926658
pubmed_primary_22672476
crossref_citationtrail_10_1111_j_1460_9592_2012_03897_x
crossref_primary_10_1111_j_1460_9592_2012_03897_x
wiley_primary_10_1111_j_1460_9592_2012_03897_x_PAN3897
istex_primary_ark_67375_WNG_S5SJ59VK_1
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2012-08
August 2012
2012-08-00
2012-Aug
20120801
PublicationDateYYYYMMDD 2012-08-01
PublicationDate_xml – month: 08
  year: 2012
  text: 2012-08
PublicationDecade 2010
PublicationPlace Oxford, UK
PublicationPlace_xml – name: Oxford, UK
– name: France
– name: Glasgow
PublicationTitle Pediatric anesthesia
PublicationTitleAlternate Paediatr Anaesth
PublicationYear 2012
Publisher Blackwell Publishing Ltd
Wiley Subscription Services, Inc
Publisher_xml – name: Blackwell Publishing Ltd
– name: Wiley Subscription Services, Inc
References Moores C, Rogers JG, McKenzie IM et al. Anaesthesia for children with mucopolysaccharidoses. Anaesth Intensive Care 1996; 24: 259-463.
Hobbs JR, Hugh-Jones K, Barrett AJ et al. Reversal of clinical features of Hurler's disease and biochemical improvement after treatment by bone-marrow transplantation. Lancet 1981; 2: 709-712.
Boelens JJ, Wynn RF, O'Meara A et al. Outcomes of hematopoietic stem cell transplantation for Hurler's syndrome in Europe: a risk factor analysis for graft failure. Bone Marrow Transplant 2007; 40: 225-233.
Sifuentes M, Doroshow R, Hoft R et al. A follow -up study of MPS I patients treated with laronidase enzyme replacement therapy for 6 years. Mol Genet Metab 2007; 90: 171-180.
Weisstein JS, Delgado E, Steinbach LS et al. Musculoskeletal manifestations of Hurler syndrome: long term follow up after bone marrow transplantation. J Pediatr Orthop 2004; 24: 97-101.
Walker RW, Darowski M, Morris P et al. Anaesthesia and mucopolysaccharidoses. A review of airway problems in children. Anaesthesia 1994; 49: 1078-1084.
Walker RWM. The laryngeal mask airway in the difficult paediatric airway: an assessment of positioning and use in fibreoptic intubation. Paediatr Anaesth 2000; 10: 53-58.
Walker RWM, Colovic V, Robinson DN et al. Postobstructive pulmonary oedema during anaesthesia in children with mucopolysaccharidoses. Paediatr Anaesth 2003; 13: 441-447.
Wraith JE, Clarke LA, Beck M et al. Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human α-l-iduronidase (laronidase). J Pediatr 2004; 144: 581-588.
Walker RWM, Allen DL, Rothera M. A fibreoptic intubation technique for children with mucopolysaccaridoses using the laryngeal mask airway. Paediatr Anaesth 1997; 7: 421-426.
Smith RM. Anaesthesia for Infants and Children, 4th edn. St Louis, MO: C.V. Mosby Co, 1980: 533-536.
Baines D, Keneally J. Anaesthetic implications of the mucopolysaccharidoses: a fifteen-year experience in a children's hospital. Anaesth Intensive Care 1983; 11: 198-202.
Muenzer J, Wraith JE, Clarke LA. Mucopolysaccharidosis I: management and treatment guidelines. Pediatrics 2009; 123: 19-29.
Braunlin EA, Berry JM, Whitley CB. Cardiac findings after enzyme replacement therapy for mucopolysaccharidosis type I. Am J Cardiol 2006; 98: 416-418.
2004; 144
2001
2006; 98
2000; 10
1981; 2
2004; 24
2003; 13
2007; 90
2009; 123
1994; 49
2007; 40
1980
1996; 24
1983; 11
1997; 7
e_1_2_7_4_2
e_1_2_7_8_2
e_1_2_7_7_2
e_1_2_7_6_2
e_1_2_7_16_2
e_1_2_7_15_2
e_1_2_7_14_2
e_1_2_7_13_2
e_1_2_7_12_2
Moores C (e_1_2_7_3_2) 1996; 24
e_1_2_7_11_2
e_1_2_7_10_2
Neufeld EF (e_1_2_7_9_2) 2001
Baines D (e_1_2_7_5_2) 1983; 11
Smith RM (e_1_2_7_2_2) 1980
References_xml – reference: Hobbs JR, Hugh-Jones K, Barrett AJ et al. Reversal of clinical features of Hurler's disease and biochemical improvement after treatment by bone-marrow transplantation. Lancet 1981; 2: 709-712.
– reference: Muenzer J, Wraith JE, Clarke LA. Mucopolysaccharidosis I: management and treatment guidelines. Pediatrics 2009; 123: 19-29.
– reference: Sifuentes M, Doroshow R, Hoft R et al. A follow -up study of MPS I patients treated with laronidase enzyme replacement therapy for 6 years. Mol Genet Metab 2007; 90: 171-180.
– reference: Walker RW, Darowski M, Morris P et al. Anaesthesia and mucopolysaccharidoses. A review of airway problems in children. Anaesthesia 1994; 49: 1078-1084.
– reference: Smith RM. Anaesthesia for Infants and Children, 4th edn. St Louis, MO: C.V. Mosby Co, 1980: 533-536.
– reference: Walker RWM. The laryngeal mask airway in the difficult paediatric airway: an assessment of positioning and use in fibreoptic intubation. Paediatr Anaesth 2000; 10: 53-58.
– reference: Walker RWM, Allen DL, Rothera M. A fibreoptic intubation technique for children with mucopolysaccaridoses using the laryngeal mask airway. Paediatr Anaesth 1997; 7: 421-426.
– reference: Weisstein JS, Delgado E, Steinbach LS et al. Musculoskeletal manifestations of Hurler syndrome: long term follow up after bone marrow transplantation. J Pediatr Orthop 2004; 24: 97-101.
– reference: Braunlin EA, Berry JM, Whitley CB. Cardiac findings after enzyme replacement therapy for mucopolysaccharidosis type I. Am J Cardiol 2006; 98: 416-418.
– reference: Moores C, Rogers JG, McKenzie IM et al. Anaesthesia for children with mucopolysaccharidoses. Anaesth Intensive Care 1996; 24: 259-463.
– reference: Wraith JE, Clarke LA, Beck M et al. Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human α-l-iduronidase (laronidase). J Pediatr 2004; 144: 581-588.
– reference: Boelens JJ, Wynn RF, O'Meara A et al. Outcomes of hematopoietic stem cell transplantation for Hurler's syndrome in Europe: a risk factor analysis for graft failure. Bone Marrow Transplant 2007; 40: 225-233.
– reference: Walker RWM, Colovic V, Robinson DN et al. Postobstructive pulmonary oedema during anaesthesia in children with mucopolysaccharidoses. Paediatr Anaesth 2003; 13: 441-447.
– reference: Baines D, Keneally J. Anaesthetic implications of the mucopolysaccharidoses: a fifteen-year experience in a children's hospital. Anaesth Intensive Care 1983; 11: 198-202.
– volume: 2
  start-page: 709
  year: 1981
  end-page: 712
  article-title: Reversal of clinical features of Hurler’s disease and biochemical improvement after treatment by bone‐marrow transplantation
  publication-title: Lancet
– volume: 7
  start-page: 421
  year: 1997
  end-page: 426
  article-title: A fibreoptic intubation technique for children with mucopolysaccaridoses using the laryngeal mask airway
  publication-title: Paediatr Anaesth
– volume: 24
  start-page: 259
  year: 1996
  end-page: 463
  article-title: Anaesthesia for children with mucopolysaccharidoses
  publication-title: Anaesth Intensive Care
– volume: 11
  start-page: 198
  year: 1983
  end-page: 202
  article-title: Anaesthetic implications of the mucopolysaccharidoses: a fifteen‐year experience in a children’s hospital
  publication-title: Anaesth Intensive Care
– volume: 24
  start-page: 97
  year: 2004
  end-page: 101
  article-title: Musculoskeletal manifestations of Hurler syndrome: long term follow up after bone marrow transplantation
  publication-title: J Pediatr Orthop
– volume: 10
  start-page: 53
  year: 2000
  end-page: 58
  article-title: The laryngeal mask airway in the difficult paediatric airway: an assessment of positioning and use in fibreoptic intubation
  publication-title: Paediatr Anaesth
– volume: 49
  start-page: 1078
  year: 1994
  end-page: 1084
  article-title: Anaesthesia and mucopolysaccharidoses. A review of airway problems in children
  publication-title: Anaesthesia
– start-page: 3421
  year: 2001
  end-page: 3452
– volume: 123
  start-page: 19
  year: 2009
  end-page: 29
  article-title: Mucopolysaccharidosis I: management and treatment guidelines
  publication-title: Pediatrics
– volume: 144
  start-page: 581
  year: 2004
  end-page: 588
  article-title: Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double‐blinded, placebo‐controlled, multinational study of recombinant human α‐l‐iduronidase (laronidase)
  publication-title: J Pediatr
– volume: 40
  start-page: 225
  year: 2007
  end-page: 233
  article-title: Outcomes of hematopoietic stem cell transplantation for Hurler’s syndrome in Europe: a risk factor analysis for graft failure
  publication-title: Bone Marrow Transplant
– volume: 90
  start-page: 171
  year: 2007
  end-page: 180
  article-title: A follow –up study of MPS I patients treated with laronidase enzyme replacement therapy for 6 years
  publication-title: Mol Genet Metab
– volume: 13
  start-page: 441
  year: 2003
  end-page: 447
  article-title: Postobstructive pulmonary oedema during anaesthesia in children with mucopolysaccharidoses
  publication-title: Paediatr Anaesth
– volume: 98
  start-page: 416
  year: 2006
  end-page: 418
  article-title: Cardiac findings after enzyme replacement therapy for mucopolysaccharidosis type I
  publication-title: Am J Cardiol
– start-page: 533
  year: 1980
  end-page: 536
– ident: e_1_2_7_6_2
  doi: 10.1016/S0140-6736(81)91046-1
– ident: e_1_2_7_13_2
  doi: 10.1016/j.ymgme.2006.08.007
– ident: e_1_2_7_8_2
  doi: 10.1046/j.1460-9592.1997.d01-102.x
– ident: e_1_2_7_11_2
  doi: 10.1038/sj.bmt.1705718
– ident: e_1_2_7_12_2
  doi: 10.1097/01241398-200401000-00019
– ident: e_1_2_7_14_2
  doi: 10.1016/j.amjcard.2006.02.047
– volume: 24
  start-page: 259
  year: 1996
  ident: e_1_2_7_3_2
  article-title: Anaesthesia for children with mucopolysaccharidoses
  publication-title: Anaesth Intensive Care
  doi: 10.1177/0310057X9602400408
– ident: e_1_2_7_10_2
  doi: 10.1542/peds.2008-0416
– ident: e_1_2_7_4_2
  doi: 10.1111/j.1365-2044.1994.tb04360.x
– start-page: 533
  volume-title: Anaesthesia for Infants and Children
  year: 1980
  ident: e_1_2_7_2_2
– ident: e_1_2_7_15_2
  doi: 10.1046/j.1460-9592.2000.00425.x
– ident: e_1_2_7_16_2
  doi: 10.1046/j.1460-9592.2003.00969.x
– ident: e_1_2_7_7_2
  doi: 10.1016/j.jpeds.2004.01.046
– start-page: 3421
  volume-title: The Metabolic and Molecular Basis of Inherited Disease
  year: 2001
  ident: e_1_2_7_9_2
– volume: 11
  start-page: 198
  year: 1983
  ident: e_1_2_7_5_2
  article-title: Anaesthetic implications of the mucopolysaccharidoses: a fifteen‐year experience in a children’s hospital
  publication-title: Anaesth Intensive Care
  doi: 10.1177/0310057X8301100303
SSID ssj0013262
Score 2.1620421
Snippet Summary Aim:  To assess the effect of bone marrow transplantation (BMT), enzyme replacement therapy (ERT), and a fiberoptic endotracheal intubation technique...
Aim:  To assess the effect of bone marrow transplantation (BMT), enzyme replacement therapy (ERT), and a fiberoptic endotracheal intubation technique in...
To assess the effect of bone marrow transplantation (BMT), enzyme replacement therapy (ERT), and a fiberoptic endotracheal intubation technique in patients...
Summary Aim: To assess the effect of bone marrow transplantation (BMT), enzyme replacement therapy (ERT), and a fiberoptic endotracheal intubation technique in...
SourceID proquest
pubmed
crossref
wiley
istex
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 745
SubjectTerms Adolescent
Airway management
Airway Management - methods
Anesthesia
Bone marrow
Bone Marrow Transplantation - methods
Child
Child, Preschool
difficult airway
Enzyme Replacement Therapy
Female
Fiber Optic Technology
Humans
Hurler syndrome
Infant
Intubation
Laryngeal Masks
Laryngoscopy
Male
mucopolysaccharidoses
Mucopolysaccharidosis I - physiopathology
Mucopolysaccharidosis I - surgery
Mucopolysaccharidosis I - therapy
Patients
Retrospective Studies
Transplants & implants
Treatment Failure
Title Mucopolysaccharidosis type I (Hurler syndrome) and anesthesia: the impact of bone marrow transplantation, enzyme replacement therapy, and fiberoptic intubation on airway management
URI https://api.istex.fr/ark:/67375/WNG-S5SJ59VK-1/fulltext.pdf
https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1460-9592.2012.03897.x
https://www.ncbi.nlm.nih.gov/pubmed/22672476
https://www.proquest.com/docview/1334926658
https://www.proquest.com/docview/1023534139
Volume 22
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3fb9MwELbQJiFeYPxc2JiMhBBIS5U0sZ3w1gGlDLVCjMHeLMe5iKprippWrPu7-AO5c9KITnuYEFKjRm0vjePz3efz3WfGXpgY3SZRzoaZkn6cQ-obRMl-loJKJORRBBTvGI7k4DQ-PhNnTf4T1cLU_BBtwI1GhrPXNMBNVl0d5IGfipTqqSikh75XdQhPUuoW4aMv3b8WFNzeooh_hE8EKptJPddeaMNTbdNDv7gOhm6iWueW-vfYZN2gOhtl0lkuso69vML1-H9avMPuNuiV92p1u89uQfmA3R426_MP2e_h0tKuC6vKWKrnGuezalxxivPyj_zVAO8I5nzNkvCamzLHA9v5A6qxecPxndd1m3xW8GxWAp86lki-cCTs56aulCoPOZSXqynwObisMopx8rqWbHXoLlu4VBg0iJaP0a9mTozjy4znv8yKT9u8n0fstP_-69uB3-wL4VsEd8pPFfHwEbbDyVIhZGRMGBUWJARGZkIayKGweRIbnA1CFNhQyiRQqUgitDYmix6zrRJbsMs4igogl5zGIg6DIiF-_64KbAIQJhY8ptY6oG1Dmk57d5zrjclToKlTNHWKdp2iLzwWtpI_a-KQG8i8dGrWCpj5hBLvlNDfRx_0iTg5Fum3Tzr02P5aD3VjcyodRsQ0KRFSeux5-zVaC1oCwr6cLfE3RG9EwCX12JNaf9s_QyCuurGSHpNOC2982_pzb0RnT_9VcI_doY_rvMp9trWYL-EZYr1FdsC2e0fvjvoHbjT_AYk8Rsk
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1tb9MwELbQJgFfeH8JDDASQiAtVdLEdsK3CTG6l1aIbbBvluNcRLU2RUkr1v0ufiB3ThrRaR8mhNSolZpL4vjse3y-e46xNyZGs0mUs2GmpB_nkPoGUbKfpaASCXkUAfk7hiM5OIn3T8VpWw6IcmEafojO4UYjw83XNMDJIX15lAd-KlJKqCKfHhpf1UNAuUkFvt366mv_ry0FV10UEZDwiUJlPaznyiut2apNeu3nVwHRdVzrDNPuXTZZNamJRznrLeZZz15cYnv8T22-x-60AJbvNBp3n92A8gG7OWy36B-y38OFpcILy9pYSuka57N6XHNy9fI9_m6AjwQVXxElvOemzPHAhv6Aemw-cPzmTeomnxU8m5XAp44oks8dD_vENMlS5TaH8mI5BV6BCywjNydv0smW2-6yhYuGwTnR8jGa1syJcfyYcfXLLPm0C_15xE52Px1_HPhtaQjfIr5TfqqIio_gHa6XCiEjY8KosCAhMDIT0kAOhc2T2OCCEKLAhlImgUpFEuGEY7LoMdsosQVPGUdRAWSV01jEYVAkRPHfV4FNAMLEgsfUSgm0bXnTqXzHRK-tnwJNnaKpU7TrFH3usbCT_Nlwh1xD5q3Ts07AVGcUe6eE_j76rI_E0b5Ivx3o0GNbK0XU7bRT6zAiskmJqNJjr7u_ccKgXSDsy9kCzyGGI8IuqceeNArc3QyxuOrHSnpMOjW89mPrLzsj-vXsXwVfsVuD4-GhPtwbHTxnt-mUJsxyi23MqwW8QOg3z166If0HnYFJcg
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1tb9MwELbQJk184f0lMMBICIG0VEkT2wnfJkbpNlpNjMG-WY5zEVXXdGpase538QO5c9KITvswIaRGrdJcGtfnu8fnu8eMvTExuk2inA0zJf04h9Q3iJL9LAWVSMijCCjeMRjK_kl8cCpOm_wnqoWp-SHagBuNDGevaYCf58XVQR74qUipnopCeuh7VQfx5CaeT0jD9752_1pRcJuLIgASPjGorGf1XHunNVe1Sf_6xXU4dB3WOr_Uu8vGqxbV6SjjzmKedezlFbLH_9Pke-xOA1_5bq1v99ktKB-wrUGzQP-Q_R4sLG27sKyMpYKuUT6tRhWnQC_f5-_6-EQw4yuahPfclDke2M6fUI3MB47vvC7c5NOCZ9MS-MTRRPK5Y2E_M3WpVLnDobxcToDPwKWVUZCT18Vkyx1328LlwqBFtHyEjjVzYhxfZjT7ZZZ80ib-PGInvU_fPvb9ZmMI3yK6U36qiIiPwB3OlgohI2PCqLAgITAyE9JADoXNk9jgdBCiwIZSJoFKRRKhuTFZ9JhtlNiCp4yjqADyyWks4jAoEiL476rAJgBhYsFjaqUD2jas6bR5x5lemz0FmjpFU6do1yn6wmNhK3leM4fcQOatU7NWwMzGlHmnhP4x_KyPxfGBSL8f6tBj2ys91I3RqXQYEdWkREzpsdft12guaA0I-3K6wGuI34iQS-qxJ7X-tj-GSFx1YyU9Jp0W3vix9dHukD49-1fBV2zraK-nv-wPD5-z23RFnWO5zTbmswW8QNw3z166Af0HlwZIKg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Mucopolysaccharidosis+type+I+%28Hurler+syndrome%29+and+anesthesia%3A+the+impact+of+bone+marrow+transplantation%2C+enzyme+replacement+therapy%2C+and+fiberoptic+intubation+on+airway+management&rft.jtitle=Pediatric+anesthesia&rft.au=Kirkpatrick%2C+Katherine&rft.au=Ellwood%2C+James&rft.au=Walker%2C+Robert+W+M&rft.date=2012-08-01&rft.issn=1460-9592&rft.eissn=1460-9592&rft.volume=22&rft.issue=8&rft.spage=745&rft_id=info:doi/10.1111%2Fj.1460-9592.2012.03897.x&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1155-5645&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1155-5645&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1155-5645&client=summon